ofloxacin and rufloxacin

ofloxacin has been researched along with rufloxacin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's2 (20.00)18.2507
2000's4 (40.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cecchetti, V; Fravolini, A; Fringuelli, R; Mascellani, G; Pagella, P; Palmioli, M; Segre, G; Terni, P1
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B1
Bellotti, M; Mattina, R; Raimondi, A; Sander, K1
Norte, V; Panchal, S; Piddock, LJ1
Choi, EC; Choi, KH; Hong, JS; Kim, SK; Lee, DK; Yoon, SJ1
Belvedere, A; Boscá, F; Catalfo, A; Cuquerella, MC; De Guidi, G; Miranda, MA1
Boldrini, E; Campa, M; Celandroni, F; Davini, P; Ghelardi, E; Parisio, E; Salvetti, S; Senesi, S; Tavanti, A1
Andreeva, I; Rafalsky, V; Rjabkova, E1
Drlica, K; German, N; Kerns, RJ; Malik, M; Marks, KR; Schwanz, HA1
Chen, XY; Ge, ZZ; Gu, LY; Li, XB; Lin, WW; Lu, H1

Reviews

1 review(s) available for ofloxacin and rufloxacin

ArticleYear
Quinolones for uncomplicated acute cystitis in women.
    The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3

    Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic

2006

Trials

1 trial(s) available for ofloxacin and rufloxacin

ArticleYear
Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study.
    Helicobacter, 2011, Volume: 16, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; China; Drug Therapy, Combination; Female; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organometallic Compounds; Pantoprazole; Pilot Projects; Salvage Therapy; Treatment Outcome; Young Adult

2011

Other Studies

8 other study(ies) available for ofloxacin and rufloxacin

ArticleYear
Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:3

    Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyridones; Spectrophotometry, Infrared; Thiazines

1987
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
    Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11

    Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Administration, Oral; Animals; Anti-Infective Agents; Fluoroquinolones; Klebsiella pneumoniae; Ofloxacin; Quinolones; Rats

1987
Comparison of the mechanism of action and resistance of two new fluoroquinolones, rufloxacin and MF961 with those of ofloxacin and fleroxacin in gram-negative and gram-positive bacteria.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:6

    Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mutation; Ofloxacin; Quinolones; Rec A Recombinases

1993
In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus

1997
Photochemical properties of ofloxacin involved in oxidative DNA damage: a comparison with rufloxacin.
    Chemical research in toxicology, 2003, Volume: 16, Issue:4

    Topics: Anti-Bacterial Agents; DNA Damage; Fluorescence; Fluoroquinolones; Hydrogen Peroxide; Lasers; Ofloxacin; Oxidation-Reduction; Photochemistry; Quinolones; Time Factors

2003
A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Adhesives; Administration, Topical; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Colony Count, Microbial; Excipients; Eye; Fluoroquinolones; Keratitis; Mucous Membrane; Ofloxacin; Plant Extracts; Pseudomonas Infections; Quinolones; Rabbits; Seeds; Staphylococcal Infections; Tamarindus

2004
Effect of N-1/c-8 ring fusion and C-7 ring structure on fluoroquinolone lethality.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Anti-Infective Agents; Chloramphenicol; Escherichia coli; Fluoroquinolones; Levofloxacin; Ofloxacin; Oxazines; Structure-Activity Relationship

2010